✦ LIBER ✦

A randomized controlled trial of CDP571, a humanized antibody to TNFA, in moderately to severely active Crohn's disease

✍ Scribed by Sanborn, William J.; Targan, Stephan R.; Hanauer, Stephan B.; Present, Daniel H.; Sutherland, Lloyod R.; Kamm, Michael A.; Wolf, Doug C.; Baker, J.P.; Hawkey, Chriatopher J.; Heath, Patricia K.; Feagan, Brian G.

Book ID: 123397282
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 165 KB
Volume: 118
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(00)84760-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A six-month open label evaluation of CDP

A six-month open label evaluation of CDP571, a humanized antibody to TNFa, in active Crohn's disease

✍ Sandborn, William J.; Targan, Stephan R.; Hanauer, Stephen B.; Present, Daniel H 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 181 KB

A randomized, placebo-controlled trial o

A randomized, placebo-controlled trial of CDP571, a humanized monoclonal antibody to TNF-α, in patients with moderate to severe Crohn's disease

✍ William J. Sandborn; Brian Feagan; Graham Radford-Smith; Agota Kovacs; Robert En 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 168 KB

An engineered human antibody to TNF (CDP

An engineered human antibody to TNF (CDP571) for active crohn's disease: A randomized double-blind placebo-controlled trial

✍ William J. Sandborn; Brian G. Feagan; Stephen B. Hanauer; Daniel H. Present; Llo 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 160 KB

649 A Randomized Placebo-Controlled Tria

649 A Randomized Placebo-Controlled Trial of Abatacept for Moderately-to-Severely Active Crohn's Disease (CD)

✍ Stephen B. Hanauer; William J. Sandborn; Bruce E. Sands; Paul J. Rutgeerts; Remo 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 76 KB

A Randomized Placebo-Controlled Trial of

A Randomized Placebo-Controlled Trial of a Humanized Monoclonal Antibody to α4 Integrin in Active Crohn's Disease

✍ Fiona H. Gordon; Clement W.Y. Lai; Mark I. Hamilton; Miles C. Allison; Emmanuel 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 245 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-α, in patients with corticosteroid-dependent Crohn's disease

✍ B. G. Feagan; W. J. Sandborn; J. P. Baker; F. Cominelli; L. R. Sutherland; C. O 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 331 KB